Stocks · Health care · Biological Products, (No Diagnostic Substances)

Revolution Medicines, Inc.

RVMD Clue Score22
United States Fiscal year ends December CIK 0001628171 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Mark A Goldsmith
6 Feb 2026
See Remarks
Exercised, kept
24,010
$0.54
$12.97K
Mark A Goldsmith
30 Jun 2025
See Remarks
Exercised, kept
37,000
$0.54
$19.98K
Mark A Goldsmith
18 Dec 2024
See Remarks
Exercised, kept
30,846
$0.49
$15.11K
Showing 250 of 518 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 373
Amendments (4/A) skipped 9
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 119
Sales straight out of an exercise 253
Sales at will 95
Transactions with no price 1
Shares from compensation/vesting 35,863,308
Sales filed before the plan box existed 81
History held since 14 Feb 2020